HomeInsightsPB

Astrazeneca Pharma India Ltd PB Ratio

Astrazeneca Pharma India Ltd PB Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

0.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PB

26.4

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Astrazeneca Pharma India Ltd is 26.4 as of 07 Nov 24.
  • The P/B Ratio of Astrazeneca Pharma India Ltd changed from 12.5 on March 2022 to 18.7 on March 2024 . This represents a CAGR of 14.37% over 3 years. .

Historical P/B Ratio of Astrazeneca Pharma India Ltd

No data available

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

18,792 Cr

EPS

52.4

P/E Ratio (TTM) *

143.4

P/B Ratio (TTM) *

26.4

Day’s High *

7543.05

Day’s Low

7365.4

DTE *

0.0

ROE *

22.7

52 Week High

8139.85

52 Week Low

4050.15

ROCE *

30.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20247517
06 Nov 20247608.65
05 Nov 20247478
04 Nov 20247379.4
01 Nov 20247550.3
31 Oct 20247606.7
30 Oct 20247349.05
29 Oct 20247386.55
28 Oct 20247055.65
25 Oct 20247139.75

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Astrazeneca Pharma India Ltd2618,792
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5051,58,179
Cipla Ltd3621,27,063
Mankind Pharma Ltd2641,09,234
Dr Reddys Laboratories Ltd3171,07,398

Key Valuation Metric of Astrazeneca Pharma India Ltd

Share Price

₹7,384

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 202416:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 202408:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 202412:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...

Read more

24 Sep 202414:30

News

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter...

Read more

08 Aug 202416:08

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 8...

Read more

24 Jul 202416:06

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Astrazeneca Pharma India Ltd

What is the PB ratio of Astrazeneca Pharma India Ltd?

The current PB ratio of Astrazeneca Pharma India Ltd is 26.4. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Astrazeneca Pharma India Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Astrazeneca Pharma India Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Astrazeneca Pharma India Ltd calculated?

The PB ratio of Astrazeneca Pharma India Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Astrazeneca Pharma India Ltd?

A high PB ratio suggests that Astrazeneca Pharma India Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Astrazeneca Pharma India Ltd?

A low PB ratio of Astrazeneca Pharma India Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Astrazeneca Pharma India Ltd PB Ratio change over time?

Yes, the PB ratio of Astrazeneca Pharma India Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*